The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy

被引：0
|
作者：
Neboori, H. [1 ,2 ]
Wu, H. [1 ]
Schiff, D. [1 ]
Goyal, S. [1 ]
Moran, M. [3 ]
Yang, J.
Hirshfield, K. M. [1 ]
Haffty, B. G. [1 ]
机构：
[1] UMDNJ, New Brunswick, NJ USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[3] Yale Univ, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [31] Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
    Tudhope, Sue
    Zhao, Yan
    Wittner, Anita
    Wilmore, Elaine
    Bertoli, Annalisa
    Adhikari, Santosh
    Harnor, Suzannah J.
    Del Bello, Fabio
    Piergentili, Alessandro
    Lunec, John
    Hardcastle, Ian R.
    Griffin, Roger J.
    Golding, Bernard R.
    Cano, Celine
    Newell, David R.
    Wedge, Stephen R.
    CANCER RESEARCH, 2014, 74 (19)
  • [32] The expression of MDM2 and p53 protein breast carcinoma
    Hideshima, T
    Shinohara, T
    Baba, M
    Shirakusa, T
    ONCOLOGY REPORTS, 1997, 4 (02) : 297 - 300
  • [33] Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity
    Giglio, S.
    Mancini, F.
    Pellegrino, M.
    Di Conza, G.
    Puxeddu, E.
    Sacchi, A.
    Pontecorvi, A.
    Moretti, F.
    ONCOGENE, 2010, 29 (44) : 5935 - 5945
  • [34] MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond
    Marine, Jean-Christophe
    Jochemsen, Aart G.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (07):
  • [35] Reactivation of p53 signaling in hepatoblastoma with a stapled peptide dual inhibitor of MDM2 and MDM4
    Woodfield, Sarah E.
    Patel, Roma H.
    Ibarra, Aryana M.
    Chen, Zhenghu
    Vasudevan, Sanjeev A.
    CANCER RESEARCH, 2018, 78 (19)
  • [36] Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
    Xiong, SB
    Van Pelt, CS
    Elizondo-Fraire, AC
    Liu, G
    Lozano, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3226 - 3231
  • [37] Expression of MDM2, MDM4 and p53 and Association with Outcome in 162 Cases of Gastric Adenocarcinoma
    Rock, J. B.
    Hatzaras, I. S.
    Suarez, A. A.
    Zhou, X.
    Bloomston, M. P.
    Frankel, W. L.
    MODERN PATHOLOGY, 2011, 24 : 166A - 166A
  • [38] Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
    Pellegrino, Marsha
    Mancini, Francesca
    Luca, Rossella
    Coletti, Alice
    Giacche, Nicola
    Manni, Isabella
    Arisi, Ivan
    Florenzano, Fulvio
    Teveroni, Emanuela
    Buttarelli, Marianna
    Fici, Laura
    Brandi, Rossella
    Bruno, Tiziana
    Fanciulli, Maurizio
    D'Onofrio, Mara
    Piaggio, Giulia
    Pellicciari, Roberto
    Pontecorvi, Alfredo
    Marine, Jean Christophe
    Macchiarulo, Antonio
    Moretti, Fabiola
    CANCER RESEARCH, 2015, 75 (21) : 4560 - 4572
  • [39] Regulation of MDM4 (MDMX) function by p76MDM2: a new facet in the control of p53 activity
    S Giglio
    F Mancini
    M Pellegrino
    G Di Conza
    E Puxeddu
    A Sacchi
    A Pontecorvi
    F Moretti
    Oncogene, 2010, 29 : 5935 - 5945
  • [40] Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
    Francoz, S
    Froment, P
    Bogaerts, S
    De Clercq, S
    Maetens, M
    Doumont, G
    Bellefroid, E
    Marine, JC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3232 - 3237
12345